Research Progress on D-Allulose: Physiological Functions and Enzymatic Biotransformation

If you’re sourcing ingredients for a reduced-sugar product, D-allulose should be on your list. A 2021 review in Foods (DOI: 10.3390/foods10092186) lays out why this rare sugar matters. It also shows what still needs attention: enzyme-driven biotransformation and production scale.

The background

D-allulose is a low-calorie sugar substitute. It appears naturally in small quantities in some fruits and grains. But nature doesn't produce enough for commercial use. Manufacturers need enzymatic biotransformation to convert other sugars into D-allulose at scale.

The review frames D-allulose as more than a sweetener. It calls it a food ingredient and a dietary supplement with physiological functions. Those functions include improving insulin resistance, fighting obesity, and regulating glucolipid metabolism. That last term simply means glucose and lipid metabolism. For formulators, that opens the door to positioning products not just as “sugar-free” but as functional.

What the study did

This is a review paper, not a new clinical trial. The authors gathered and assessed the available research on D-allulose across three areas: physiological functions, enzymatic biotransformation technology, and production process.

They also examined regulatory status. The paper confirms that D-allulose has received FDA GRAS certification and has been approved for use in various foods and dietary supplements. That matters because regulatory acceptance removes one of the biggest hurdles when you bring a new ingredient to a buyer.

Key findings at a glance

The review’s core message is that D-allulose’s value goes beyond sweetness. For ingredient buyers, the physiological functions are the main draw. For production managers, the biotransformation process is the bottleneck.

Physiological function	What that means for product development
Improving insulin resistance	Supports functional positioning for blood sugar management
Anti-obesity	Fits reduced-calorie and weight-management product claims
Regulating glucolipid metabolism	Broadens appeal for metabolic health and wellness applications

The review makes clear that D-allulose can be a dual-purpose ingredient. You can use it as a bulk sweetener in place of sugar. You can also use it as an active component in a functional formulation. That dual role gives you more room to justify cost and premium pricing.

But there is a catch. You need a reliable production route. The review highlights enzymatic biotransformation as the key technology. It does not pretend the process is simple. It looks at how enzymes convert substrates into D-allulose and how the production process determines yield, purity, and scalability. For an ingredient buyer, those are not abstract details. They decide whether your supplier can meet volume commitments.

What it means for manufacturers

You can move forward with D-allulose in US-market products. The GRAS status gives you regulatory cover. The approval in multiple food categories and dietary supplements makes it a flexible option.

Your formula will still need work. D-allulose behaves differently from sucrose in browning, solubility, and freezing point. You have to adjust for those. The review does not provide those formulation details, but it gives you the physiological and regulatory background to make the business case.

When you source D-allulose, ask how the supplier makes it. Enzymatic biotransformation is not a single, uniform process. Differences in enzyme selection, reaction conditions, and downstream purification affect quality and cost. The review points directly at this as a key area of research progress and process development. Buyers who understand that will have better conversations with suppliers.

There is also room for differentiation. D-allulose is already GRAS and approved, but consumer awareness is still growing. If you can document the physiological functions cited in the review, you can build a product story that goes beyond “less sugar.” That is valuable in a crowded marketplace.

Frequently asked questions

Is D-allulose approved for use in food products? Yes. The review states that D-allulose has received FDA GRAS certification and has been approved as an ingredient in various foods and dietary supplements.

What are the main physiological functions of D-allulose? The review highlights improved insulin resistance, anti-obesity effects, and regulation of glucolipid metabolism.

Why does enzymatic biotransformation matter to ingredient buyers? Because that process determines production efficiency and scalability. A supplier with a solid enzymatic biotransformation process is more likely to provide consistent, cost-effective D-allulose supply.

The research community continues to push D-allulose forward. This review gives food formulators and ingredient buyers a clear view of the ingredient’s current standing. The regulatory door is open. The functional evidence is strong. What remains is the production work. Read the full paper if you want the technical details on enzymes and processing. Then use those details to ask better questions.